Cd7-positive Hematological Malignancies

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-01-16
Clinical Trial Update: Clinical Study on the Safety and Efficacy of CD7-Targeted Chimeric Antigen Receptor (CAR) Gene-Modified T Cells for the Treatment of CD7-Positive Hematological Malignancies [NA]
A clinical study is evaluating CD7-targeted CAR T cells for CD7-positive hematological malignancies. The trial status is not yet recruiting.